DOI: 10.12890/2024_004611

Before symptomatic internal carotid artery stenoses can be attributed to giant cell arteritis, other causes must be ruled out

Authors

  • Josef Finsterer Neurology & Neurophysiology Centre, Vienna, Austria

fifigs1@yahoo.de

Keywords

Giant cell arteritis, vasculitis, ischaemic stroke, endovascular therapy, cardiovascular risk profile

Abstract

.

View the entire article

Downloads

References

  1. Órfao A, Saca C, Alexandre I, Oliveira AM, Fernandes Serôdio J, Barreira J, et al. Giant cell arteritis presenting as multiple ischaemic strokes: a successful case of endovascular treatment. Eur J Case Rep Intern Med 2024;11:004296.
  2. Terré A, Lidove O, Georges O, Mesnildrey P, Chennebault H, Ziza JM. Non-infective endocarditis: expanding the phenotype of giant cell arteritis. Joint Bone Spine 2019;86:115–116.
  3. Kafantari E, Sotiropoulou M, Sfikakis P, Dimitrakakis K, Zagouri F, Mandrekas K, et al. Giant cell arteritis of the breast and breast cancer: paraneoplastic manifestation or concomitant disease? A case report. Onkologie 2008;31:685–688.
  4. Aguiar T, Vincent MB. Giant cell arteritis and polymyalgia rheumatica as first manifestation of typical pulmonary carcinoid tumor. Reumatismo 2015;67:165–168.

Published

2024-05-31

How to Cite

1.
Finsterer J. Before symptomatic internal carotid artery stenoses can be attributed to giant cell arteritis, other causes must be ruled out. EJCRIM [Internet]. 2024 May 31 [cited 2026 Nov. 3];11(7). Available from: https://ejcrim.com/index.php/ejcrim/article/view/4611

Most read articles by the same author(s)